short description
(Photo: © Getty Images/JurgaR)

Global Challenges Seminar on Vaccines: Accelerating Innovation and Access

In collaboration with Access to Medicine Foundation and WHO, WIPO will hold a Global Challenges seminar during which the Global Challenges Report "Vaccines: Accelerating Innovation and Access" will be launched.

The seminar considers the challenge of reaching global immunization coverage through increasing access to current and future vaccines. It will examine the role of biopharmaceutical and vaccine manufacturers, look at how the vaccine market works, explore the role of product development partnerships in the field, and discuss the Access to Vaccines Index published by the Access to Medicine Foundation.

Meeting documents  | Practical Information | Video on Demand

Date: November 8, 2017

Time: 14:00-18:00 (CET)
Location: Room NB 0.107, WIPO HQ, Geneva

The event is open to all and will be held in English.

Register

Global Challenges report: Vaccines Accelerating Innovation and Access

The report describes the innovation process for vaccines; limitations to vaccine access at various stages, including those related to intellectual property; as well as  approaches for addressing these impediments.

Opening remarks

Photo of Minelik Alemu GetahunMinelik Alemu Getahun

WIPO Deputy Director General, Global Issues Sector

Keynote

Photo of Seth Berkley Seth Berkley

CEO, Gavi - The Vaccine Alliance, Geneva, Switzerland

Respondent

Nora Dellepiane

Senior Regulatory Adviser to Serum Institute of India, Trélex, Switzerland

Closing remarks

Photo of Anatole KrattigerAnatole Krattiger

WIPO Director, Global Challenges Division

Session one

The Access to Vaccines Index:  How Vaccine Companies are Responding to Calls for Greater Immunization Coverage

This session will include a discussion about how vaccine companies are responding to global calls to increase access to vaccines, drawing on findings from the Access to Vaccines Index, published by the Access to Medicine Foundation in March 2017. The Index is the first data-driven tool to map the landscape of vaccine company policy and behavior for making vaccines more accessible to communities that need them. By uncovering which practices are working, where and why, the Index is intended to help ensure global vaccine markets can serve all populations.

Speaker

Jayasree K. Iyer

Executive Director, Access to Medicine Foundation, Amsterdam, Netherlands

Session two

The WHO Perspective on Achieving Access to Vaccines:  Where are we now and What Needs to be Done?

During this session, Mr. Martin Friede, Coordinator of the Initiative for Vaccine Research at WHO, will present WHO’s viewpoint on achieving access to vaccines. He will discuss the current context with respect to the vaccine landscape, some key issues at play, and steps that need to be taken to increase access including IP-related factors.

Speaker

Martin Howell Friede

Coordinator, Initiative for Vaccine Research (IVR), WHO, Geneva,  Switzerland

Session three

Moderated panel discussion on the launch of the Global Challenges Report Vaccines: Accelerating Innovation and Access followed

During this session, the new Global Challenges Report Vaccines: Accelerating Innovation and Access will be launched.  Panelists representing Médecins Sans Frontières, the Coalition for Epidemic Preparedness Innovations, UNICEF, Industry and the Access to Medicine Foundation will offer their perspectives and engage the audience in a discussion around relevant issues brought to light in the report.

 


Moderated by Koenraad Debackere, Professor, University of Leuven, Belgium

Panelists

Hilde Stevens

Professor, Baillet Latour Chair in Translational Medicine (13h, ULB)

Rohit Malpani

Director of Policy & Analysis, Access Campaign, Medecins sans frontières (MSF), Geneva, Switzerland

Frederick Kristensen

Deputy CEO, Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway

Heather Deehan

Chief, Vaccine Centre, United Nations Children’s Fund (UNICEF) Supply Division, Copenhagen, Denmark

An Vermeersch

Vice President, Head, Global Health and Corporate affairs, GSK Vaccines, Brussels, Belgium

Jayasree K. Iyer

Executive Director, Access to Medicine Foundation, Amsterdam, Netherlands